Product Overview: Tirzepatide is a novel once-weekly injectable peptide medication that acts as a dual GIP (glucose-dependent insulinotropic polypeptide) receptor agonist and GLP-1 (glucagon-like peptide-1) receptor agonist
There are two main steps of treatment, which include: Consultation Before your first treatment, you will need to attend a consultation appointment that will allow us to determine if you are a good candidate for this treatment
In the refrigerator at 28C, reconstituted DSIP is typically stable for around 28 days
FIGURE 5 4.6 Delayed gastric emptying GLP-1RAs has been shown to delay gastric emptying (Jelsing et al., 2012), thereby extending the retention of food in the stomach and small intestine and reducing postprandial glucose levels (Winkler et al., 2019)
Prioritising adequate sleep and managing stress are key components of metabolic health
Klinic can connect you with knowledgeable providers who understand the landscape of medical weight loss in Round Lake, Illinois
